US Stem Cell Inc (USRM)

[Rizzler]

Agreed. Think about it.

They locked in a price for 63 Million shares as they feel that the chances for RMAT approval are high. However, Smart Money is typically SMART and wants to make sure that they don't expose themselves to high RISK.

Remember, Stem Cells are a game changer which means BIG Pharma will be hit the most.

I am loading here as I am leaning towards what General American is doing.

$2.5M for clinics
$5 M for Corporate

Thats a lot for a Penny company.